ID27788A - Peptida-peptida antigen tumor yang diperoleh dari siklofilin b - Google Patents

Peptida-peptida antigen tumor yang diperoleh dari siklofilin b

Info

Publication number
ID27788A
ID27788A IDW20002735A ID20002735A ID27788A ID 27788 A ID27788 A ID 27788A ID W20002735 A IDW20002735 A ID W20002735A ID 20002735 A ID20002735 A ID 20002735A ID 27788 A ID27788 A ID 27788A
Authority
ID
Indonesia
Prior art keywords
cyclophilins
tumor
cyclefilin
antigenal
derivatives
Prior art date
Application number
IDW20002735A
Other languages
English (en)
Inventor
Kyogo Itoh
Shinya Gomi
Original Assignee
Kyogo Itoh Cs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyogo Itoh Cs filed Critical Kyogo Itoh Cs
Publication of ID27788A publication Critical patent/ID27788A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
IDW20002735A 1998-06-25 1999-06-24 Peptida-peptida antigen tumor yang diperoleh dari siklofilin b ID27788A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17844998 1998-06-25

Publications (1)

Publication Number Publication Date
ID27788A true ID27788A (id) 2001-04-26

Family

ID=16048723

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002735A ID27788A (id) 1998-06-25 1999-06-24 Peptida-peptida antigen tumor yang diperoleh dari siklofilin b

Country Status (15)

Country Link
US (2) US7041297B1 (id)
EP (1) EP1090924B8 (id)
JP (1) JP4413429B2 (id)
KR (1) KR100653590B1 (id)
CN (1) CN1318447C (id)
AT (1) ATE375362T1 (id)
AU (1) AU749544B2 (id)
CA (1) CA2331761A1 (id)
DE (1) DE69937294T2 (id)
ES (1) ES2294844T3 (id)
HK (1) HK1067645A1 (id)
ID (1) ID27788A (id)
NZ (1) NZ508996A (id)
TW (1) TWI228128B (id)
WO (1) WO1999067288A1 (id)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105306B1 (en) * 2000-08-10 2006-09-12 Trustees Of The University Of Pennsylvania Methods and compositions for modulating somatolactogenic functions
EP1212078B1 (en) * 1999-09-10 2005-06-22 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Ant-1 as drug target
WO2001052858A1 (en) * 2000-01-24 2001-07-26 Trustees Of Tufts College Tetracycline compounds for treatment of cryptosporidium parvum related disorders
EP1286954B1 (en) 2000-05-15 2004-04-14 Paratek Pharmaceuticals, Inc. 7-substituted fused ring tetracycline compounds
US20020128238A1 (en) * 2000-06-16 2002-09-12 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
WO2003055441A2 (en) * 2001-08-02 2003-07-10 Paratek Pharmaceuticals, Inc. Medicaments
WO2004024766A1 (ja) 2002-09-12 2004-03-25 Oncotherapy Science, Inc. Kdrペプチド及びこれを含むワクチン
WO2005029083A1 (en) * 2003-09-22 2005-03-31 Green Peptide Co., Ltd. Prognosis in cancer patients vaccinated with a cancer antigen peptide-associated agent
TWI261038B (en) * 2004-08-11 2006-09-01 Bo-Cheng Chen Bicycle gear-shifting handgrip
EP2301912A3 (en) 2004-10-25 2012-07-11 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
US9017957B2 (en) 2006-05-01 2015-04-28 Hitachi Chemical Company, Ltd. Prostasin partial peptide and anti-prostasin antibody
WO2008045507A2 (en) 2006-10-11 2008-04-17 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of bacillus anthracis infections
US20100009920A1 (en) 2006-12-13 2010-01-14 Yusuke Nakamura Ttk as tumor marker and therapeutic target for lung cancer
KR101493775B1 (ko) 2007-02-16 2015-02-16 온코세라피 사이언스 가부시키가이샤 맥락막 신생혈관용 백신 치료
TW201425333A (zh) 2007-04-11 2014-07-01 Oncotherapy Science Inc 腫瘤血管內皮標誌８胜肽及包含此胜肽之疫苗
CN101835893A (zh) 2007-08-24 2010-09-15 肿瘤疗法科学股份有限公司 癌症相关基因cdca5、epha7、stk31和wdhd1
CN101854945B (zh) 2007-09-18 2015-07-01 株式会社绿多肽 Ctl诱导剂组合物
US8518912B2 (en) 2007-11-29 2013-08-27 Actelion Pharmaceuticals Ltd. Phosphonic acid derivates and their use as P2Y12 receptor antagonists
TWI526219B (zh) 2008-06-19 2016-03-21 腫瘤療法 科學股份有限公司 Ｃｄｃａ１抗原決定位胜肽及含此胜肽的疫苗
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
TWI539160B (zh) 2008-12-05 2016-06-21 腫瘤療法 科學股份有限公司 Ｗｄｒｐｕｈ抗原決定位胜肽以及含此胜肽之疫苗
TWI469791B (zh) 2009-02-18 2015-01-21 Oncotherapy Science Inc Ｆｏｘｍ１胜肽以及含此胜肽之疫苗
JP5799394B2 (ja) 2009-03-18 2015-10-28 オンコセラピー・サイエンス株式会社 Ｎｅｉｌ３ペプチドおよびそれを含むワクチン
TWI507204B (zh) 2009-05-26 2015-11-11 Oncotherapy Science Inc Ｃｄｃ４５ｌ胜肽與含此胜肽之疫苗
TW201136604A (en) 2009-12-14 2011-11-01 Oncotherapy Science Inc TMEM22 peptides and vaccines including the same
SG10201501857YA (en) 2010-03-11 2015-05-28 Oncotherapy Science Inc Hjurp Peptides And Vaccines Including The Same
US9725490B2 (en) 2011-07-29 2017-08-08 Tokushima University ERAP1-derived peptide and use thereof
CA2842887C (en) 2011-08-12 2021-01-19 Oncotherapy Science, Inc. Mphosph1 peptides and vaccines including the same
MX355759B (es) 2011-10-28 2018-04-27 Oncotherapy Science Inc Peptidos topk y vacunas que incluyen los mismos.
JP6259983B2 (ja) 2012-07-10 2018-01-17 オンコセラピー・サイエンス株式会社 Ｔｈ１細胞のＫＩＦ２０Ａエピトープペプチドおよびこれを含有するワクチン
JP6255594B2 (ja) 2012-07-10 2018-01-10 オンコセラピー・サイエンス株式会社 Ｔｈ１細胞のＬＹ６Ｋエピトープペプチドおよびこれを含有するワクチン
MX362912B (es) 2012-09-11 2019-02-22 Oncotherapy Science Inc Péptidos ube2t y vacunas que incluyen los mismos.
TWI658049B (zh) 2013-03-12 2019-05-01 腫瘤療法 科學股份有限公司 Ｋｎｔｃ２胜肽及含此胜肽之疫苗
ES2796301T3 (es) 2013-10-21 2020-11-26 Taiho Pharmaceutical Co Ltd Nuevo péptido con cuatro epítopos CTL unidos
ES2856834T3 (es) 2014-08-04 2021-09-28 Oncotherapy Science Inc Péptido derivado de URLC10 y vacuna que contiene el mismo
CN111925431A (zh) 2014-08-04 2020-11-13 肿瘤疗法科学股份有限公司 Koc1衍生的肽和包含它们的疫苗
US10676514B2 (en) 2014-08-04 2020-06-09 Oncotherapy Science, Inc. CDCA1-derived peptide and vaccine containing same
MX2018004308A (es) 2015-10-08 2018-05-01 Oncotherapy Science Inc Peptido derivado de foxm1 y vacuna que lo incluye.
JP6716801B2 (ja) 2018-06-29 2020-07-01 大鵬薬品工業株式会社 抗腫瘍剤及びその評価方法
TW202023581A (zh) 2018-08-02 2020-07-01 日商腫瘤療法 科學股份有限公司 來自cdca1的胜肽及含有此的疫苗
WO2020111167A1 (ja) 2018-11-30 2020-06-04 国立大学法人徳島大学 Ｂｉｇ３－ｐｈｂ２相互作用阻害ｐｈｂ２由来ペプチドを含む乳がん治療薬
EP4082563A4 (en) 2019-12-26 2024-02-28 Taiho Pharmaceutical Co., Ltd. POST-OPERATIVE ADJUVANT THERAPY AGENT
CN115078727A (zh) * 2022-07-13 2022-09-20 首都医科大学附属北京胸科医院 一种预测癌症免疫治疗效果的标志物、试剂盒与应用
DE102022118517A1 (de) 2022-07-25 2024-01-25 Dennis Reitmeir Liegestützvorrichtung mit drehbaren Griffeinheiten
CN115372618A (zh) * 2022-09-19 2022-11-22 首都医科大学附属北京胸科医院 一种检测蛋白标志物水平的试剂在制备用于评估肿瘤治疗效果的诊断产品中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0326067A3 (en) * 1988-01-26 1991-04-17 The Du Pont Merck Pharmaceutical Company Use of cyclophilin as an anti-inflammatory and immunomodulatory agent
IL106610A0 (en) * 1992-08-07 1993-12-08 Cytel Corp Hla binding peptides and their uses
JPH09151200A (ja) * 1995-09-29 1997-06-10 Ajinomoto Co Inc ヒト胃癌に対する免疫応答を誘導できるペプチド及び該ペプチドを含むヒト胃癌治療、予防剤
US5840839A (en) * 1996-02-09 1998-11-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein

Also Published As

Publication number Publication date
EP1090924B1 (en) 2007-10-10
ES2294844T3 (es) 2008-04-01
HK1067645A1 (en) 2005-04-15
US7041297B1 (en) 2006-05-09
EP1090924A4 (en) 2002-07-10
TWI228128B (en) 2005-02-21
KR100653590B1 (ko) 2006-12-04
NZ508996A (en) 2003-09-26
EP1090924B8 (en) 2007-11-21
AU4392699A (en) 2000-01-10
CN1318447C (zh) 2007-05-30
US20060008463A1 (en) 2006-01-12
JP4413429B2 (ja) 2010-02-10
CN1525980A (zh) 2004-09-01
WO1999067288A9 (fr) 2000-03-30
AU749544B2 (en) 2002-06-27
ATE375362T1 (de) 2007-10-15
KR20010053180A (ko) 2001-06-25
EP1090924A1 (en) 2001-04-11
US7368107B2 (en) 2008-05-06
WO1999067288A1 (fr) 1999-12-29
DE69937294D1 (de) 2007-11-22
CA2331761A1 (en) 1999-12-29
DE69937294T2 (de) 2008-07-03

Similar Documents

Publication Publication Date Title
ID27788A (id) Peptida-peptida antigen tumor yang diperoleh dari siklofilin b
EP2022800A3 (en) Compositions for the therapy and diagnosis of ovarian cancer
DE69738754D1 (de) Hemmer der interaktion zwischen p53 und mdm2
IL125590A (en) Peptide immunogens, process for their preparation and use thereof as vaccines against allergies
BR9907259A (pt) Compostos para terapia e diagnóstico de câncer de pulmão e processos para o seu uso
NZ516381A (en) Lung tumor proteins in the therapy and diagnosis of lung cancer
AU2001235006A1 (en) Prophylactic and therapeutic monoclonal antibodies
DE60239707D1 (de) Antimikrobielle kationische peptide und diese enthaltende formulierungen
WO1999033869A3 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
WO2000078344A8 (en) Prion protein peptides and uses thereof
JPS5231839A (en) Drug for cosmetics and permanent wave in combination
WO1997018790A3 (en) Therapeutic and diagnostic agents for the treatment of microbial infections
WO2000061756A3 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
EP1762620A3 (en) Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof
NZ510154A (en) A tumour antigen protein and gene therefor, tumour antigen peptides and derivatives thereof in medicaments and prophylactics
EP1364657A4 (en) REMEDIES AGAINST TUMORS AFFECTING HEMATOPOIETIC BODIES
ZA971403B (en) Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof.
WO2004047757A3 (en) Diagnosing and treating hematopoietic cancers
WO2001029220A3 (en) Mage-a12 antigenic peptides and uses thereof
DE50114335D1 (de) Lh-rh-antagonisten, deren herstellung und verwendung als arzneimittel
ID27162A (id) Peptida antigen tumor yang dibatasi hla-a2 yang berasal dari sart-1
CY1108790T1 (el) Συνθεσεις για τη θεραπεια και διαγνωση ωοθηκικου καρκινου
WO2002100346A3 (en) (r, r'),(r',s')-amphetaminil, compositions and uses thereof
EP2003201A3 (en) Compounds and methods for therapy and diagnosis of lung cancer